Seikagaku Corp (4548)

Currency in JPY
648.0
+5.0(+0.78%)
Closed·
4548 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
4548 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
643.0652.0
52 wk Range
603.0883.0
Key Statistics
Bid/Ask
648.00 / 654.00
Prev. Close
643
Open
645
Day's Range
643-652
52 wk Range
603-883
Volume
138.6K
Average Volume (3m)
154.36K
1-Year Change
-23.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4548 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Seikagaku Corp Company Profile

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals and medical devices manufacturing processes and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for knee osteoarthritis; SI-722 to treat interstitial cystitis and bladder pain syndrome; SI-613-ETP to treat enthesopathy; and SI-449, a cross-linked chondroitin sulfate adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

Employees
1075
Market
Japan

Compare 4548 to Peers and Sector

Metrics to compare
4548
Peers
Sector
Relationship
P/E Ratio
−39.9x12.9x−0.5x
PEG Ratio
0.280.150.00
Price/Book
0.5x1.0x2.6x
Price / LTM Sales
0.9x1.5x3.3x
Upside (Analyst Target)
-12.9%40.1%
Fair Value Upside
Unlock11.3%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -16.25%
Dividend Yield
4.63%
Industry Median 2.48%
Annualised payout
30.00
Paid unevenly
5-Years Growth
+2.90%
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-3.68 / --
Revenue / Forecast
8.73B / --
EPS Revisions
Last 90 days

4548 Income Statement

FAQ

What Stock Exchange Does Seikagaku Corp Trade On?

Seikagaku Corp is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Seikagaku Corp?

The stock symbol for Seikagaku Corp is "4548."

What Is the Seikagaku Corp Market Cap?

As of today, Seikagaku Corp market cap is 35.37B.

What Is Seikagaku Corp's Earnings Per Share (TTM)?

The Seikagaku Corp EPS (TTM) is -16.25.

When Is the Next Seikagaku Corp Earnings Date?

Seikagaku Corp will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is 4548 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Seikagaku Corp Stock Split?

Seikagaku Corp has split 4 times.

How Many Employees Does Seikagaku Corp Have?

Seikagaku Corp has 1075 employees.

What is the current trading status of Seikagaku Corp (4548)?

As of 17 Aug 2025, Seikagaku Corp (4548) is trading at a price of 648.00, with a previous close of 643.00. The stock has fluctuated within a day range of 643.00 to 652.00, while its 52-week range spans from 603.00 to 883.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.